−1.61 MUSD
112.95 M
About EOM Pharmaceutical Holdings Inc.
Sector
CEO
Irach B. Taraporewala
Headquarters
Montvale
Website
Founded
1987
ISIN
US4525364026
FIGI
BBG000PQD8D8
EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company, which engages in the development of drugs with the potential to transform therapeutic paradigms. Its pipeline includes EOM613 and EOM147. The company was founded on March 20, 1987 and is headquartered in Montvale, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of IMUC is 0.20 USD — it has increased by 39.27% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange EOM Pharmaceutical Holdings Inc. stocks are traded under the ticker IMUC.
EOM Pharmaceutical Holdings Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track EOM Pharmaceutical Holdings Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, IMUC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EOM Pharmaceutical Holdings Inc. stock right from TradingView charts — choose your broker and connect to your account.